Loading clinical trials...

Exploring the Potential Benefits of Probiotic Yogurt | Clinical Trials | Clareo Health

RECRUITINGNA

Exploring the Potential Benefits of Probiotic Yogurt

Exploring the Potential Benefits of High-activity Probiotic Yogurt: a Randomized, Double-blind, Placebo-controlled Trial

NCT06847919•Wecare Probiotics Co., Ltd.

View on ClinicalTrials.gov

Summary

This study aims to evaluate the effect of a high-activity probiotic yogurt on improving symptoms of chronic constipation, observing its regulatory effects on the gut microbiota and the incidence of adverse reactions in study participants over a 21-day intervention period.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Meet the Rome IV diagnosis criteria for chronic constipation;
•2. Patients who are able to understand clinical studies and are committed to complying with study requirements and procedures;
•3. Age 18-65. -

Exclusion Criteria

•1. Systemic (diabetes, autoimmune diseases, cancer), gastrointestinal or liver diseases known to be associated with alterations in the gut microbiota;
•2. Patients who are pregnant or lactating;
•3. have taken antimicrobials, probiotics, or drugs that inhibit stomach acid or gastrointestinal motility in the past 6 weeks;
•4. Patients who changed their diet type during the study;
•5. Patients who are allergic or intolerant to any component of the investigational product formulation;
•6. Patients with cardiovascular, cerebrovascular, liver, kidney and hematopoietic system and other serious diseases and endocrine diseases, mental patients;
•7. Stop taking the tested sample or add other drugs in the middle, unable to judge the efficacy or incomplete data;
•8. short-term use of objects related to the function of the test, affecting the judgment of the result;
•9. have been dieting, exercising excessively, taking weight loss medications or taking medications that may affect appetite in the past 3 months;
•10. Current or past excessive use of alcohol, drugs, or supplements that may cause intestinal dysfunction or interfere with the evaluation of the efficacy of the study product -

Locations (1)

Suzhou Ninth People's Hospital Suzhou Ninth Hospital affiliated to Soochow University

Suzhou, Jiangsu, China

Key Dates

Start Date

February 25, 2025

Primary Completion Date

September 30, 2025

Completion Date

December 30, 2025

Last Updated

March 5, 2025

Enrollment

ESTIMATED participants

Conditions

Chronic Constipation

Interventions

Probiotic yogurt group

DIETARY_SUPPLEMENT

Yogurt control group

DIETARY_SUPPLEMENT

Contacts

Ying Jin, Doctor

CONTACT

13375163966 sunny13211@sina.com

Sacral Neuromodulation as Treatment for Chronic Constipation

NCT03819062

Chronic Constipation

View study

ACTIVE_NOT_RECRUITINGNA

"Which Type of Exercise is More Effective in Chronic Constipation?

NCT06354855

Chronic Constipation

View study

COMPLETEDNA

Validation of New Type Radiopaque Marker in The Evaluation of Colonic Transit Time

NCT06850415

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Exploring the Potential Benefits of Probiotic Yogurt

Inclusion Criteria

Exclusion Criteria

Sacral Neuromodulation as Treatment for Chronic Constipation

"Which Type of Exercise is More Effective in Chronic Constipation?

Validation of New Type Radiopaque Marker in The Evaluation of Colonic Transit Time

Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation

Effectiveness and Safety of Probiotic in Regulating Chronic Constipation

Long-term Elobixibat for Chronic Constipation